Arlington, MA, United States of America

David James Edmonds

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 8.8

ph-index = 5

Forward Citations = 65(Granted Patents)


Location History:

  • Pawcatuck, CT (US) (2014)
  • Arlington, MA (US) (2016 - 2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Inventor Spotlight: David James Edmonds

Introduction

David James Edmonds is a noteworthy inventor based in Arlington, Massachusetts. With an impressive portfolio of 12 patents, Edmonds has made significant contributions to the field of pharmaceutical science.

Latest Patents

Among his latest innovations are the patents for Diacylglycerol acyltransferase 2 inhibitors. These compounds are characterized by a specific formula defined within the patent documentation. The disclosed compounds serve as valuable inhibitors for diacylglycerol acyltransferase 2 (DGAT2). They are particularly relevant for developing pharmaceutical compositions aimed at treating conditions such as Non-Alcoholic Steatohepatitis (NASH).

Career Highlights

David currently works at Pfizer Corporation, a leading global pharmaceutical company. His work mainly focuses on developing innovative solutions that address complex health issues. The advancements he has made in his field have helped establish him as a prominent figure in pharmaceutical research.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Kentaro Futatsugi and David Andrew Griffith. These partnerships have enabled the exchange of ideas and fostered innovations that contribute to the advancement of science and technology.

Conclusion

With his extensive research and numerous patents, David James Edmonds continues to be a significant force in the field of pharmaceutical innovation. His work at Pfizer Corporation and collaboration with esteemed professionals exemplify his commitment to improving healthcare through advanced scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…